Dial-in Number
| Web session
|
HL7 Antitrust Policy
Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).
Attendees
Please include your organization in your Zoom name.
- Click on your picture/name in Zoom
- Click on rename
- enter <name> - <organization>
Name | Organization | Present |
---|---|---|
Danielle Bancroft | Best Practice Software | |
Melva Peters (Scribe) | Jenaker Consulting | |
Jean Duteau (Chair) | Duteau Design | |
John Hatem | Independent Consultant (Chair) | x |
Scott Robertson | Kaiser Permanente (Scribe) | x |
Christof Gessner | HL7 Germany | |
Corey Spears | MITRE | |
Dave Hill | MITRE | |
Frank McKinney | POCP | x |
Isaac Vetter | Epic | |
Joseph Quinn (Joe) | Smile Digital Health | x |
Lawrence Lo | Columbia University HIT Student | |
Margaret Weiker | NCPDP | |
Matt Szczepankiewicz | Epic | |
Peter Sergent | HL7 New Zealand | |
Reed D. Gelzer | Trustworthy EHR | |
Shelly Spiro | Pharmacy HIT Collaborative | x |
Stephen Chu | ADHA | x |
Tim McNeil | Surescripts | x |
Kim Roberts | Pharmacy HIT Collaborative | x |
Phung Matthews | 3M | |
Jack Brashier | Epic | |
Emmanuel Obasuyi | ||
Joel Montavon | PQA | |
Robb Young | PharmID | |
Christopher Isong | ||
Gary Schoettmer | NetRx | |
Courtney Bland | CVS / Aetna | |
Mark Neumuth | Aetna | |
Ed Millikan | FDA | |
Sanket Raval | CVS / Aetna | |
James Tcheng | ||
Peter Muir | x | |
Joe Kelly | Surescripts | |
Peter Jordan | ||
Jose Costa Teixeira | x | |
Jeff Shick | USP | |
Kent Bulza | Artera | x |
Agenda Items and Notes
Outstanding Action Item List
Meeting Notes from previous meeting
- 2022-11-21 - accepted by acclimation
Project Proposals
- PSS-2137 Data exchange industry – Pharmaceutical Quality (Dxi-PQ) - Jira (hl7.org)
- will not request involvement
Project Scope Statements
Project Scope Statements - none to review
External Meeting Review
Catalog Updates (John Hatem)
- - No meeting last week, next meeting Dec 2
Workflow Update (John Hatem)
-
- met today, working through trackers, nothing specific to pharmacy
Healthcare Product Update (John Hatem)
-
- met today. tracker on device property and device metric. much discussion on when to use which. 'property' is static, 'metric' can change over time. nothing specific to pharmacy.
EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)
-
- nothing to report. difficult to follow meetings (inconsistent). There is a desire to set up an HL7 project.
Potential Drug-Drug Interaction (PDDI) CDS IG
- From last week agenda: Reviewing for ballot. Call on Nov 23 at noon eastern to review. http://build.fhir.org/ig/HL7/PDDI-CDS/
- Jean, John H, Scott will attend
- Clinical Decision Support call info
Wed Nov-23-2022 12:00PM EST
Phone Number: +1 646-558-8656 Participant Passcode: 209 701 8272
Web Meeting Info
Join Zoom Meeting https://zoom.us/j/2097018272?pwd=WC9tVWY2NnRTSmVHN21ja3gxeERqZz09
Meeting ID: 209 701 8272 Password: 343027
- Scott/John, could not join ... specifically link didn't work
NCPDP Updates (NCPDP Members)
Projects
Pharmacist Consult Note (Scott)
- - pre
Pharmacy Templates
- - Block vote status?
- John Hatem will follow up with Gorgio for status
Specialty Medication Enrolment IG
- - Jean Duteau will be scheduling calls:
- Reconciliation calls to be held for the Specialty Medication Enrollment STU2 ballot
- Thurs Dec 1 at 12 ET
- Thurs Dec 15
- Thurs Dec 22 (If required)
- IG available at https://build.fhir.org/ig/HL7/fhir-specialty-rx/index.html
- Comments at https://jira.hl7.org/issues/?filter=19560
Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)
-
-
FHIR-39319Getting issue details...
STATUS
- discussion tended to not agree with Rik, but the description for Dosage.text needs to be clarified. Persuasive with Modification.
- considerable discussion on what the appropriate description is, what is the intent of Dosage.text
- an interim definition included in comment, although we are not in full agreement
Any Other Business
- discussion on MedicationAdministration.performer.device. who set the parameters, when set, when changed.
- Stephen will follow up with Orders